SCYX (STOCKS)
SCYNEXIS, Inc.
$5.275800
+0.465800 (+9.68%)
Prev close: $4.810000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David Angulo Gonzalez
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $51.14M
- Employees
- 29
- P/E (TTM)
- -2.61
- P/B (TTM)
- 0.72
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-3.36 | $-1.01 | -2.3536 | -233.86% |
|
Dec 2025 (Q4)
|
$1.94 | $1.03 | +0.9028 | +87.35% |
|
Sep 2025 (Q3)
|
$-1.36 | $-1.63 | +0.2720 | +16.67% |
|
Jun 2025 (Q2)
|
$-1.12 | $-1.55 | +0.4304 | +27.76% |
Financial Statements
| Revenues | $19.22M |
| Benefits Costs and Expenses | $29.45M |
| Costs And Expenses | $29.45M |
| Nonoperating Income/Loss | $12.36M |
| Operating Expenses | $41.81M |
| Selling, General, and Administrative Expenses | $15.57M |
| Research and Development | $26.24M |
| Operating Income/Loss | -$22.60M |
| Income/Loss From Continuing Operations After Tax | -$10.24M |
| Income/Loss From Continuing Operations Before Tax | -$10.24M |
| Net Income/Loss | -$10.24M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$10.24M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.24M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.29 |
| Diluted Earnings Per Share | $0.29 |
| Basic Average Shares | 112,916,523 |
| Diluted Average Shares | 112,916,523 |
| Assets | $74.97M |
| Current Assets | $56.24M |
| Cash | $71.10M |
| Noncurrent Assets | $18.73M |
| Liabilities | $8.04M |
| Current Liabilities | $5.83M |
| Accounts Payable | $3.27M |
| Other Current Liabilities | $2.56M |
| Noncurrent Liabilities | $2.22M |
| Equity | $66.93M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $66.93M |
| Liabilities And Equity | $74.97M |
| Net Cash Flow From Operating Activities | -$13.31M |
| Net Cash Flow From Operating Activities, Continuing | -$13.31M |
| Net Cash Flow From Investing Activities | -$24.69M |
| Net Cash Flow From Investing Activities, Continuing | -$24.69M |
| Net Cash Flow From Financing Activities | $37.41M |
| Net Cash Flow From Financing Activities, Continuing | $37.41M |
| Net Cash Flow | -$588.00K |
| Net Cash Flow, Continuing | -$588.00K |
| Comprehensive Income/Loss | -$10.24M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$10.24M |
| Other Comprehensive Income/Loss | $0.00 |